NIAID Banner Logo Image

Opportunistic Infections Citation List: November 22 - December 5, 2013

ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

1. 2'-Deoxyuridine 5'-monophosphate Substrate Displacement in Thymidylate Synthase through 6-Hydroxy-2H-naphtho[1,8-bc]furan-2-one Derivatives. Ferrari, S., S. Calo, R. Leone, R. Luciani, L. Costantino, S. Sammak, F. Di Pisa, C. Pozzi, S. Mangani, and M.P. Costi. Journal of Medicinal Chemistry, 2013. 56(22): p. 9356-9360. PMID[24147825].

[PubMed]. OI_1122-120513.


2. A Cysteine Protease Inhibitor Rescues Mice from a Lethal Cryptosporidium parvum Infection. Ndao, M., M. Nath-Chowdhury, M. Sajid, V. Marcus, S.T. Mashiyama, J. Sakanari, E. Chow, Z. Mackey, K.M. Land, M.P. Jacobson, C. Kalyanaraman, J.H. McKerrow, M.J. Arrowood, and C.R. Caffrey. Antimicrobial Agents and Chemotherapy, 2013. 57(12): p. 6063-6073. PMID[24060869].

[PubMed]. OI_1122-120513.


3. Effects of Dextran Sulfates on the Acute Infection and Growth Stages of Toxoplasma gondii. Ishiwa, A., K. Kobayashi, H. Takemae, T. Sugi, H. Gong, F.C. Recuenco, F. Murakoshi, A. Inomata, T. Horimoto, and K. Kato. Parasitology Research, 2013. 112(12): p. 4169-4176. PMID[24096605].

[PubMed]. OI_1122-120513.


4. Fluconazole Assists Berberine to Kill Fluconazole-resistant Candida albicans. Li, D.D., Y. Xu, D.Z. Zhang, H. Quan, E. Mylonakis, D.D. Hu, M.B. Li, L.X. Zhao, L.H. Zhu, Y. Wang, and Y.Y. Jiang. Antimicrobial Agents and Chemotherapy, 2013. 57(12): p. 6016-6027. PMID[24060867].

[PubMed]. OI_1122-120513.


5. Phenothiazine is a Potent Inhibitor of Prostaglandin E2 Production by Candida albicans Biofilms. Ells, R., G. Kemp, J. Albertyn, J.L. Kock, and C.H. Pohl. FEMS Yeast Research, 2013. 13(8): p. 849-855. PMID[24103090].

[PubMed]. OI_1122-120513.


6. Small Molecules Inhibit Growth, Viability and Ergosterol Biosynthesis in Candida albicans. Rajput, S.B. and S.M. Karuppayil. SpringerPlus, 2013. 2(1): p. 26. PMID[23449869].

[PubMed]. OI_1122-120513.


7. Synthesis and Anti-toxoplasmosis Activity of 4-Arylquinoline-2-carboxylate Derivatives. McNulty, J., R. Vemula, C. Bordon, R. Yolken, and L. Jones-Brando. Organic & Biomolecular Chemistry, 2013. [Epub ahead of print]. PMID[24276426].

[PubMed]. OI_1122-120513.

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

8. Monoterpenes with Antibacterial Activities from a Cameroonian Medicinal Plant Canthium multiflorum (Rubiaceae). Kouam, S.F., A.W. Ngouonpe, A. Bullach, M. Lamshoft, G.M. Kuigoua, and M. Spiteller. Fitoterapia, 2013. 91: p. 199-204. PMID[24028969].

[PubMed]. OI_1122-120513.


9. In Vitro Susceptibility of Mycobacterium tuberculosis to Trimethoprim and Sulfonamides in France. Ameen, S.M. and M. Drancourt. Antimicrobial Agents and Chemotherapy, 2013. 57(12): p. 6370-6371. PMID[24060877].

[PubMed]. OI_1122-120513.


10. Lipoamide Channel-binding Sulfonamides Selectively Inhibit Mycobacterial Lipoamide Dehydrogenase. Bryk, R., N. Arango, C. Maksymiuk, A. Balakrishnan, Y.T. Wu, C.H. Wong, T. Masquelin, P. Hipskind, C.D. Lima, and C. Nathan. Biochemistry, 2013. [Epub ahead of print]. PMID[24251446].

[PubMed]. OI_1122-120513.


11. Hytramycins V and I, Anti-Mycobacterium tuberculosis Hexapeptides from a Streptomyces hygroscopicus Strain. Cai, G., J.G. Napolitano, J.B. McAlpine, Y. Wang, B.U. Jaki, J.W. Suh, S.H. Yang, I.A. Lee, S.G. Franzblau, G.F. Pauli, and S. Cho. Journal of Natural Products, 2013. 76(11): p. 2009-2018. PMID[24224794].

[PubMed]. OI_1122-120513.


12. In Vitro Cross-linking of Mycobacterium tuberculosis Peptidoglycan by L,D-Transpeptidases and Inactivation of These Enzymes by Carbapenems. Cordillot, M., V. Dubee, S. Triboulet, L. Dubost, A. Marie, J.E. Hugonnet, M. Arthur, and J.L. Mainardi. Antimicrobial Agents and Chemotherapy, 2013. 57(12): p. 5940-5945. PMID[24041897].

[PubMed]. OI_1122-120513.


13. Whole-cell Screening-based Identification of Inhibitors against the Intraphagosomal Survival of Mycobacterium tuberculosis. Khare, G., P. Kumar, and A.K. Tyagi. Antimicrobial Agents and Chemotherapy, 2013. 57(12): p. 6372-6377. PMID[24060878].

[PubMed]. OI_1122-120513.


14. Synthesis and 3D-QSAR Analysis of 2-Chloroquinoline Derivatives as H37 RV MTB Inhibitors. Khunt, R.C., V.M. Khedkar, and E.C. Coutinho. Chemical Biology & Drug Design, 2013. 82(6): p. 669-684. PMID[23790070].

[PubMed]. OI_1122-120513.


15. Can Inhibitor-Resistant Substitutions in the Mycobacterium tuberculosis beta-Lactamase BlaC Lead to Clavulanate Resistance?: A Biochemical Rationale for the Use of beta-Lactam-beta-Lactamase Inhibitor Combinations. Kurz, S.G., K.A. Wolff, S. Hazra, C.R. Bethel, A.M. Hujer, K.M. Smith, Y. Xu, L.W. Tremblay, J.S. Blanchard, L. Nguyen, and R.A. Bonomo. Antimicrobial Agents and Chemotherapy, 2013. 57(12): p. 6085-6096. PMID[24060876].

[PubMed]. OI_1122-120513.


16. Gallium Nitrate Is Efficacious in Murine Models of Tuberculosis and Inhibits Key Bacterial Fe-Dependent Enzymes. Olakanmi, O., B. Kesavalu, R. Pasula, M.Y. Abdalla, L.S. Schlesinger, and B.E. Britigan. Antimicrobial Agents and Chemotherapy, 2013. 57(12): p. 6074-6080. PMID[24060870].

[PubMed]. OI_1122-120513.


17. Activity and Interactions of Levofloxacin, Linezolid, Ethambutol and Amikacin in Three-drug Combinations against Mycobacterium tuberculosis Isolates in a Human Macrophage Model. Rey-Jurado, E., G. Tudo, D. Soy, and J. Gonzalez-Martin. International Journal of Antimicrobial Agents, 2013. 42(6): p. 524-530. PMID[24080479].

[PubMed]. OI_1122-120513.


18. In Vitro Anti-mycobacterial Activity of Nine Medicinal Plants Used by Ethnic Groups in Sonora, Mexico. Robles-Zepeda, R.E., E.W. Coronado-Aceves, C.A. Velazquez-Contreras, E. Ruiz-Bustos, M. Navarro-Navarro, and A. Garibay-Escobar. BMC Complementary and Alternative Medicine, 2013. 13: p. 329. PMID[24267469].

[PubMed]. OI_1122-120513.


19. Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo. Shirude, P.S., R. Shandil, C. Sadler, M. Naik, V. Hosagrahara, S. Hameed, V. Shinde, C. Bathula, V. Humnabadkar, N. Kumar, J. Reddy, V. Panduga, S. Sharma, A. Ambady, N. Hegde, J. Whiteaker, R.E. McLaughlin, H. Gardner, P. Madhavapeddi, V. Ramachandran, P. Kaur, A. Narayan, S. Guptha, D. Awasthy, C. Narayan, J. Mahadevaswamy, K. Vishwas, V. Ahuja, A. Srivastava, K. Prabhakar, S. Bharath, R. Kale, M. Ramaiah, N.R. Choudhury, V.K. Sambandamurthy, S. Solapure, P.S. Iyer, S. Narayanan, and M. Chatterji. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[24215368].

[PubMed]. OI_1122-120513.


20. Identification and Polymorphism Discovery of the Cathelicidins, Lf-CATHs in Ranid Amphibian (Limnonectes fragilis). Yu, H., S. Cai, J. Gao, S. Zhang, Y. Lu, X. Qiao, H. Yang, and Y. Wang. The FEBS Journal, 2013. 280(23): p. 6022-6032. PMID[24028327].

[PubMed]. OI_1122-120513.


21. Ethambutol Resistance Determined by Broth Dilution Method Better Correlates with embB Mutations in MDR Tuberculosis Isolates. Zhang, Z., Y. Wang, Y. Pang, and K.M. Kam. Journal of Clinical Microbiology, 2013. [Epub ahead of print]. PMID[24285734].

[PubMed]. OI_1122-120513.

ANTIMALARIAL COMPOUNDS (Plasmodium spp.)

22. 3,5-bis(Benzylidene)-4-piperidones and Related N-acyl Analogs: A Novel Cluster of Antimalarials Targeting the Liver Stage of Plasmodium falciparum. Das, U., R.S. Singh, J. Alcorn, M.R. Hickman, R.J. Sciotti, S.E. Leed, P.J. Lee, N. Roncal, and J.R. Dimmock. Bioorganic & Medicinal Chemistry, 2013. 21(23): p. 7250-7256. PMID[24139941].

[PubMed]. OI_1122-120513.


23. Antiplasmodial Activity and Mechanism of Action of RSM-932A, a Promising Synergistic Inhibitor of Plasmodium falciparum Choline Kinase. Zimmerman, T., C. Moneriz, A. Diez, J.M. Bautista, T. Gomez Del Pulgar, A. Cebrian, and J.C. Lacal. Antimicrobial Agents and Chemotherapy, 2013. 57(12): p. 5878-5888. PMID[24041883].

[PubMed]. OI_1122-120513.


24. A Primaquine-Chloroquine Hybrid with Dual Activity against Plasmodium Liver and Blood Stages. Lodige, M., M.D. Lewis, E.S. Paulsen, H.L. Esch, G. Pradel, L. Lehmann, R. Brun, G. Bringmann, and A.K. Mueller. International Journal of Medical Microbiology, 2013. 303(8): p. 539-547. PMID[23992634].

[PubMed]. OI_1122-120513.


25. Computational and Experimental Analysis Identified 6-Diazo-5-oxonorleucine as a Potential Agent for Treating Infection by Plasmodium falciparum. Plaimas, K., Y. Wang, S.O. Rotimi, G. Olasehinde, S. Fatumo, M. Lanzer, E. Adebiyi, and R. Konig. Infection, Genetics and Evolution, 2013. 20: p. 389-395. PMID[24121016].

[PubMed]. OI_1122-120513.


26. In Vivo Antimalarial Evaluation of MAMA Decoction on Plasmodium berghei in Mice. Adepiti, A.O., A.A. Elujoba, and O.O. Bolaji. Parasitology Research, 2013. [Epub ahead of print]. PMID[24271081].

[PubMed]. OI_1122-120513.


27. Structure Elucidation and Antimalarial Activity of Apicidin F: An Apicidin-like Compound Produced by Fusarium fujikuroi. von Bargen, K.W., E.M. Niehaus, K. Bergander, R. Brun, B. Tudzynski, and H.U. Humpf. Journal of Natural Products, 2013. 76(11): p. 2136-2140. PMID[24195442].

[PubMed]. OI_1122-120513.


28. Synergy of Ferrous Ion on 5-Aminolevulinic acid-mediated Growth Inhibition of Plasmodium falciparum. Komatsuya, K., M. Hata, E.O. Balogun, K. Hikosaka, S. Suzuki, K. Takahashi, T. Tanaka, M. Nakajima, S. Ogura, S. Sato, and K. Kita. Journal of Biochemistry, 2013. 154(6): p. 501-504. PMID[24158489].

[PubMed]. OI_1122-120513.


29. Synthesis and Evaluation of the Antimalarial, Anticancer, and Caspase 3 Activities of Tetraoxane Dimers. Amewu, R.K., J. Chadwick, A. Hussain, S. Panda, R. Rinki, O. Janneh, S.A. Ward, C. Miguel, H. Burrell-Saward, L. Vivas, and P.M. O'Neill. Bioorganic & Medicinal Chemistry, 2013. 21(23): p. 7392-7397. PMID[24148834].

[PubMed]. OI_1122-120513.

Citations from the ISI Web of Knowledge Listings for O.I.

30. Identification of 1-[4-Benzyloxyphenyl)-but-3-enyl]-1H-azoles as New Class of Antitubercular and Antimicrobial Agents. Anand, N., K.K.G. Ramakrishna, M.P. Gupt, V. Chaturvedi, S. Singh, K.K. Srivastava, P. Sharma, N. Rai, R. Ramachandran, A.K. Dwivedi, V. Gupta, B. Kumar, S. Pandey, P.K. Shukla, S.K. Pandey, J. Lal, and R.P. Tripathi. ACS Medicinal Chemistry Letters, 2013. 4(10): p. 958-963. ISI[000326367200016].

[WOS]. OI_1122-120513.


31. Antifungal Effect of CopA3 Monomer Peptide via Membrane-active Mechanism and Stability to Proteolysis of Enantiomeric D-CopA3. Choi, H., J.S. Hwang, H. Kim, and D.G. Lee. Biochemical and Biophysical Research Communications, 2013. 440(1): p. 94-98. ISI[000326064900016].

[WOS]. OI_1122-120513.


32. Synthesis and Evaluation of Some Novel Precursors of Oxazolidinone Analogues of Chloroquinoline for Their Antimicrobial and Cytotoxic Potential. Devi, K., Y. Asmat, M. Agrawal, S. Sharma, and J. Dwivedi. Journal of Chemical Sciences, 2013. 125(5): p. 1093-1101. ISI[000326296800016].

[WOS]. OI_1122-120513.


33. Identification of Novel Inhibitors of Nonreplicating Mycobacterium tuberculosis using a Carbon Starvation Model. Grant, S.S., T. Kawate, P.P. Nag, M.R. Silvis, K. Gordon, S.A. Stanley, E. Kazyanskaya, R. Nietupski, A. Golas, M. Fitzgerald, S. Cho, S.G. Franzblau, and D.T. Hung. ACS Chemical Biology, 2013. 8(10): p. 2224-2234. ISI[000326121400017].

[WOS]. OI_1122-120513.


34. Structure-Activity Relationship, Cytotoxicity and Mode of Action of 2-Ester-substituted 1,5-Benzothiazepines as Potent Antifungal Agents. Kang, W., X.Q. Du, L.Z. Wang, L.J. Hu, Y.H. Dong, Y.Q. Bian, and Y. Li. Chinese Journal of Chemistry, 2013. 31(10): p. 1305-1314. ISI[000326078300012].

[WOS]. OI_1122-120513.


35. Synthesis and Characterization of 1-Carboxyphenothiazine Derivatives Bearing Nitrogen Mustard as Promising Class of Antitubercular Agents. Kataria, V.B., M.J. Solanki, A.R. Trivedi, and V.H. Shah. Letters in Drug Design & Discovery, 2013. 10(10): p. 951-956. ISI[000326344200006].

[WOS]. OI_1122-120513.


36. An Efficient Synthesis of 3'-Indolyl Substituted Pyrido[1,2-a]benzimidazoles as Potential Antimicrobial and Antioxidant Agents. Kathrotiya, H.G. and M.P. Patel. Journal of Chemical Sciences, 2013. 125(5): p. 993-1001. ISI[000326296800005].

[WOS]. OI_1122-120513.


37. GC-MS Analysis and Antimicrobial Activity of Essential Oil of Pinus roxburghii Sarg. from Northern India. Kaushik, D., P. Kaushik, A. Kumar, A.C. Rana, C. Sharma, and K.R. Aneja. Journal of Essential Oil Bearing Plants, 2013. 16(4): p. 563-567. ISI[000326340200022].

[WOS]. OI_1122-120513.


38. 1H-1,2,3-Triazole-tethered Isatin-ferrocene and Isatin-ferrocenylchalcone Conjugates: Synthesis and in Vitro Antitubercular Evaluation. Kumar, K., S. Carrere-Kremer, L. Kremer, Y. Guerardel, C. Biot, and V. Kumar. Organometallics, 2013. 32(20): p. 110-116. ISI[000326365900008].

[WOS]. OI_1122-120513.


39. Systematic Study of Non-natural Short Cationic Lipopeptides as Novel Broad-Spectrum Antimicrobial Agents. Lohan, S., S.S. Cameotra, and G.S. Bisht. Chemical Biology & Drug Design, 2013. 82(5): p. 557-566. ISI[000325989600007].

[WOS]. OI_1122-120513.


40. Discovery of Mycobacterium tuberculosis Protein Tyrosine Phosphatase B (PtpB) Inhibitors from Natural Products. Mascarello, A., M. Mori, L.D. Chiaradia-Delatorre, A.C.O. Menegatti, F. Delle Monache, F. Ferrari, R.A. Yunes, R.J. Nunes, H. Terenzi, B. Botta, and M. Botta. Plos One, 2013. 8(10): p. e77081. ISI[000325887300053].

[WOS]. OI_1122-120513.


41. Reactions of Tin and Triorganotin(IV) Isopropoxides with Thymol Derivative: Synthesis, Characterization and in Vitro Antimicrobial Screening. Matela, G., R. Aman, C. Sharma, and S. Chaudhary. Journal of the Serbian Chemical Society, 2013. 78(9): p. 1323-1333. ISI[000326199200005].

[WOS]. OI_1122-120513.


42. Synthesis and Antimicrobial Activity of Some Novel 2-Aryliden-hydrazone-thiazoles. Nastasa, C., B. Tiperciuc, S. Oniga, A. Pirnau, M. Ionescu, D. Tarlungeanu, M. Palage, P. Verite, and O. Oniga. Farmacia, 2013. 61(5): p. 1027-1036. ISI[000325909700020].

[WOS]. OI_1122-120513.


43. PIF-Pocket as a Target for C. albicans Pkh Selective Inhibitors. Pastor-Flores, D., J.O. Schulze, A. Bahi, R. Giacometti, J. Ferrer-Dalmau, S. Passeron, M. Engel, E. Suss, A. Casamayor, and R.M. Biondi. ACS Chemical Biology, 2013. 8(10): p. 2283-2292. ISI[000326121400023].

[WOS]. OI_1122-120513.


44. 6-Alkyl-, 6-Aryl- or 6-Hetaryl-7-deazapurine Ribonucleosides as Inhibitors of Human or MTB Adenosine Kinase and Potential Antimycobacterial Agents. Perlikova, P., P. Konecny, P. Naus, J. Snasel, I. Votruba, P. Dzubak, I. Pichova, M. Hajduch, and M. Hocek. MedChemComm, 2013. 4(11): p. 1497-1500. ISI[000326244600011].

[WOS]. OI_1122-120513.


45. Culture Methods Versus Flow Cytometry for the Comparative Assessment of the Antifungal Activity of Eugenia caryophyllata thunb. (Myrtaceae) Essential Oil. Saviuc, C.M., A.M. Grumezescu, C. Bleotu, A.M. Holban, M.C. Chfiriuc, P. Balaure, G. Predan, and V. Lazar. Farmacia, 2013. 61(5): p. 912-919. ISI[000325909700008].

[WOS]. OI_1122-120513.


46. New Nucleoside Inhibitors of M. tuberculosis Growth. Shmalenyuk, E.R., L.N. Chernousova, and L.A. Aleksandrova. FEBS Journal, 2013. 280: p. 368-369. ISI[000325919202168].

[WOS]. OI_1122-120513.


47. Novel Inhibitors of Mycobacterium tuberculosis Growth Based on Modified Pyrimidine Nucleosides and Their Analogues. Shmalenyuk, E.R., S.N. Kochetkov, and L.A. Alexandrova. Russian Chemical Reviews, 2013. 82(9): p. 896-915. ISI[000326262600004].

[WOS]. OI_1122-120513.


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: January 2023